Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Helissey

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]P Blanchet, E Emeville, C Helissey, et al.
La Revue De Medecine Interne|January 28, 2012
[Evans syndrome: be careful of over-diagnosis]H Eddou, C Helissey, J Konopacki, et al.
La Revue De Medecine Interne|December 4, 2012
[Fever and cancer: components of diagnosis for optimal management]Y Moussaid, M Bertaux, C Chargari, et al.
La Revue De Medecine Interne|July 23, 2013
[Neuroendocrine carcinoma of the digestive tract: a literature review]J Jacob, C Chargari, C Helissey, et al.
Frontiers in Digital Health|May 25, 2023
Effectiveness of electronic patient reporting outcomes, by a digital telemonitoring platform, for prostate cancer care: the Protecty studyC Helissey, C Parnot, C Rivière, et al.
Cancer Letters|February 22, 2015
Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trialC Helissey, F Berger, P Cottu, et al.
BMJ Military Health|August 11, 2023
What are the consequences of cancer on the return to work among French military personnel?Guillaume Vanderperre, M Lalande, O Bylicki, et al.
ESMO Open|August 27, 2021
Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD studyR de Wit, C Wülfing, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2025
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple InstitutionsM Aldea, L Zullo, V Levrat, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]P Blanchet, E Emeville, C Helissey, et al.
La Revue De Medecine Interne|January 28, 2012
[Evans syndrome: be careful of over-diagnosis]H Eddou, C Helissey, J Konopacki, et al.
La Revue De Medecine Interne|December 4, 2012
[Fever and cancer: components of diagnosis for optimal management]Y Moussaid, M Bertaux, C Chargari, et al.
La Revue De Medecine Interne|July 23, 2013
[Neuroendocrine carcinoma of the digestive tract: a literature review]J Jacob, C Chargari, C Helissey, et al.
Frontiers in Digital Health|May 25, 2023
Effectiveness of electronic patient reporting outcomes, by a digital telemonitoring platform, for prostate cancer care: the Protecty studyC Helissey, C Parnot, C Rivière, et al.
Cancer Letters|February 22, 2015
Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trialC Helissey, F Berger, P Cottu, et al.
BMJ Military Health|August 11, 2023
What are the consequences of cancer on the return to work among French military personnel?Guillaume Vanderperre, M Lalande, O Bylicki, et al.
ESMO Open|August 27, 2021
Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD studyR de Wit, C Wülfing, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2025
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple InstitutionsM Aldea, L Zullo, V Levrat, et al.
Pageof 1